» Articles » PMID: 34460037

Microglia As the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia

Overview
Publisher Springer
Date 2021 Aug 30
PMID 34460037
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Microglial activation is considered as the critical pathogenic event in diverse central nervous system disorders including cerebral ischemia. Proinflammatory responses of activated microglia have been well reported in the ischemic brain and neuroinflammatory responses of activated microglia have been believed to be the potential therapeutic strategy. However, despite having proinflammatory roles, microglia can have significant anti-inflammatory roles and they are associated with the production of growth factors which are responsible for neuroprotection and recovery after ischemic injury. Microglia can directly promote neuroprotection by preventing ischemic infarct expansion and promoting functional outcomes. Indirectly, microglia are involved in promoting anti-inflammatory responses, neurogenesis, and angiogenesis in the ischemic brain which are crucial pathophysiological events for ischemic recovery. In fact, anti-inflammatory cytokines and growth factors produced by microglia can promote neuroprotection and attenuate neurobehavioral deficits. In addition, microglia regulate phagocytosis, axonal regeneration, blood-brain barrier protection, white matter integrity, and synaptic remodeling, which are essential for ischemic recovery. Microglia can also regulate crosstalk with neurons and other cell types to promote neuroprotection and ischemic recovery. This review mainly focuses on the roles of microglia in neuroprotection and recovery following ischemic injury. Furthermore, this review also sheds the light on the therapeutic potential of microglia in stroke patients.

Citing Articles

Antioxidant and Anti-Inflammatory Activities of Methanol Extract of (Viv.) H.S. Irwin & Barneby Through Nrf2/HO-1-Mediated Inhibition of NF-κB Signaling in LPS-Stimulated Mouse Microglial Cells.

Lim J, Li X, Lee D, Yao L, Yoo G, Kim Y Int J Mol Sci. 2025; 26(5).

PMID: 40076558 PMC: 11900505. DOI: 10.3390/ijms26051932.


The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.


Weisheng-tang protects against ischemic brain injury by modulating microglia activation through the P2Y12 receptor.

Kim M, Lee D, Ryu J, Lee S, Choi B, Yun Y Front Pharmacol. 2024; 15:1347622.

PMID: 39295932 PMC: 11408171. DOI: 10.3389/fphar.2024.1347622.


Minocycline alleviates microglia ferroptosis by inhibiting HO-1 during cerebral ischemia-reperfusion injury.

Wang L, Wang Y, Wu M, Jin X, Chen Y, Guo Z Inflamm Res. 2024; 73(10):1727-1745.

PMID: 39112649 PMC: 11445363. DOI: 10.1007/s00011-024-01927-z.


S100A9 deletion in microglia/macrophages ameliorates brain injury through the STAT6/PPARγ pathway in ischemic stroke.

Liu X, Wang J, Jin J, Hu Q, Zhao T, Wang J CNS Neurosci Ther. 2024; 30(8):e14881.

PMID: 39107960 PMC: 11303267. DOI: 10.1111/cns.14881.


References
1.
Okajima T, Tsuruta F . Microglial dynamics during brain development. Neural Regen Res. 2018; 13(2):222-223. PMC: 5879885. DOI: 10.4103/1673-5374.226386. View

2.
Ravina K, Briggs D, Kislal S, Warraich Z, Nguyen T, Lam R . Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic Stroke. Int J Mol Sci. 2018; 19(12). PMC: 6321015. DOI: 10.3390/ijms19123782. View

3.
Schabitz W, Schwab S, Spranger M, Hacke W . Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1997; 17(5):500-6. DOI: 10.1097/00004647-199705000-00003. View

4.
Yang G, Chen L, Gao Z, Wang Y . Implication of microglia activation and CSF-1/CSF-1Rpathway in lumbar disc degeneration-related back pain. Mol Pain. 2018; 14:1744806918811238. PMC: 6243401. DOI: 10.1177/1744806918811238. View

5.
Lin S, Fan L, Rhodes P, Cai Z . Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol. 2009; 217(2):361-70. PMC: 2766530. DOI: 10.1016/j.expneurol.2009.03.021. View